SNIPF yields 5405.41% · MRK yields 2.76%● Live data
📍 SNIPF pulled ahead of the other in Year 1
Combined, SNIPF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SNIPF + MRK for your $10,000?
Snipp Interactive Inc., a loyalty and promotions company, focuses on developing marketing engagement platforms in the United States, Canada, Ireland, and internationally. Its solutions include shopper marketing promotions, loyalty, rewards, rebates, and receipt processing. The company also engages in designing, executing, and promoting marketing programs. Snipp Interactive Inc. offers SnippCheck, a mobile receipt processing solution that allows brands to execute purchase-based promotions and loyalty programs; SnippWin, a promotion and sweepstakes platform provides various promotions from contests and simple sweepstakes to instant win programs and tiered, multi-level games; and SnippLoyalty, a solution that allows clients to deploy from simple punch-card programs to points-based loyalty programs with rewards stores. It also provides SnippRewards, a rewards platform that offers various rewards, including movie tickets, PayPal, and other money back mechanisms; and SnippInsights Data Analytics, a tool that collects and unifies data across all the programs that clients run on the snipp platform. In addition, the company offers SnippRebates, a SaaS platform that allows brands to set up and manage single-instance or cross-portfolio rebates; and SnippRx, a solution that allows medical practitioners to distribute incentives like coupons and pay-no-more cards direct to patients via text or email. It serves advertising agencies, brands and related marketing, and promotions agencies. Snipp Interactive Inc. was founded in 2007 and is headquartered in Vancouver, Canada.
Full SNIPF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.